BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26787841)

  • 1. MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells.
    Mazar J; Qi F; Lee B; Marchica J; Govindarajan S; Shelley J; Li JL; Ray A; Perera RJ
    Mol Cell Biol; 2016 Jan; 36(7):1090-108. PubMed ID: 26787841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
    Mills CN; Joshi SS; Niles RM
    Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.
    Zhou J; Xu D; Xie H; Tang J; Liu R; Li J; Wang S; Chen X; Su J; Zhou X; Xia K; He Q; Chen J; Xiong W; Cao P; Cao K
    Cancer Biol Ther; 2015; 16(6):846-55. PubMed ID: 25891797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
    Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
    Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
    Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells.
    Cheng JC; Klausen C; Leung PC
    Cancer Lett; 2013 Feb; 329(2):197-206. PubMed ID: 23142284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions.
    Mandl M; Kapeller B; Lieber R; Macfelda K
    Biochem Biophys Res Commun; 2013 Apr; 434(1):166-72. PubMed ID: 23541582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α.
    Yeh YM; Chuang CM; Chao KC; Wang LH
    Int J Cancer; 2013 Aug; 133(4):867-78. PubMed ID: 23389731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
    Kumar SM; Yu H; Edwards R; Chen L; Kazianis S; Brafford P; Acs G; Herlyn M; Xu X
    Cancer Res; 2007 Apr; 67(7):3177-84. PubMed ID: 17409425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1α-mediated glycolysis.
    Chen Y; Zhang Z; Luo C; Chen Z; Zhou J
    Oncol Rep; 2016 Jul; 36(1):471-9. PubMed ID: 27220837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-nonachlor decreases miR-141-3p levels in human melanocytes in vitro promoting melanoma cell characteristics and shows a multigenerational impact on miR-8 levels in Drosophila.
    Verrando P; Capovilla M; Rahmani R
    Toxicology; 2016 Aug; 368-369():129-141. PubMed ID: 27616325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
    Chen X; Wang J; Shen H; Lu J; Li C; Hu DN; Dong XD; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1193-9. PubMed ID: 21051724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.
    Panza E; Ercolano G; De Cicco P; Armogida C; Scognamiglio G; Botti G; Cirino G; Ianaro A
    Biochem Pharmacol; 2018 Oct; 156():52-59. PubMed ID: 30098313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
    Camps C; Buffa FM; Colella S; Moore J; Sotiriou C; Sheldon H; Harris AL; Gleadle JM; Ragoussis J
    Clin Cancer Res; 2008 Mar; 14(5):1340-8. PubMed ID: 18316553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
    Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
    Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.